What Affects Buprenorphine/Naloxone Dosage?

Medically reviewed by Seena Chokshi, Pharm.D.

Written by Kelsey Stalvey, Pharm.D.

Posted on September 3, 2026

Feel better informed on opioid use disorder and get real support from your community.

Join

Key Takeaways

Buprenorphine/naloxone, also known as Suboxone, is a treatment for opioid use disorder that works by helping reduce withdrawal symptoms and cravings, and finding the right dose looks different for everyone.

View all takeaways

When people start treatment for opioid use disorder (OUD), one of the first questions they may have is about buprenorphine/naloxone (Suboxone) dosage. It’s an understandable question, but there’s no single answer.

Buprenorphine/naloxone treatment isn’t about finding a universal dose. It’s about finding the dose that helps manage withdrawal symptoms and cravings while supporting long-term recovery.

That’s why healthcare providers don’t use a one-size-fits-all approach. Instead, they consider where someone is in treatment, how their body responds, their medical history, and several other factors. As treatment progresses, those needs can change. A dose that works well during one phase of recovery may not be the best fit later on.

🗳️ Have you talked with your doctor about whether your buprenorphine/naloxone dose is working for you?

Yes, and it was helpful.

Yes, but it wasn’t helpful.

No, but I plan to.

No, and I don’t plan to.

Understanding what influences buprenorphine/naloxone dosing can help you know what to expect during treatment and why it’s important to work closely with your healthcare provider rather than making changes on your own.

Why Buprenorphine/Naloxone Dosing Is Individualized

Buprenorphine/naloxone combines two medications. Buprenorphine is a partial opioid agonist that helps reduce withdrawal symptoms and opioid craving without producing the same effects as full opioid agonists. Naloxone is included primarily to discourage misuse by injection because it has minimal effect when the medication is taken as prescribed.

The goal of treatment isn’t to take the highest possible dose. Instead, it’s to find the lowest effective dose that controls withdrawal symptoms and cravings while minimizing side effects. Clinical practice guidelines from the American Society of Addiction Medicine and the Substance Abuse and Mental Health Services Administration emphasize individualized treatment plans based on each person’s clinical response rather than a predetermined dose.

Because OUD affects people differently, healthcare providers regularly reassess whether treatment continues to meet a person’s needs.

How the Treatment Stage Influences Dosing

Buprenorphine/naloxone treatment typically progresses through several phases. Each phase has different goals.

Induction

Induction is the beginning of treatment, when buprenorphine/naloxone is first started after a person has entered opioid withdrawal. Starting treatment too soon after using opioids can trigger precipitated withdrawal, which is why providers carefully consider the timing of the first dose and often use tools such as the Clinical Opiate Withdrawal Scale (COWS) to assess withdrawal severity.

During induction, healthcare providers monitor withdrawal symptoms, side effects, and signs that treatment may need adjustment. The goal is to help the person transition safely to medication treatment.

Maintenance

Maintenance is the long-term phase of treatment. The goal is to continue preventing withdrawal symptoms and reducing cravings while supporting recovery, counseling, and other aspects of care.

A maintenance dose isn’t necessarily permanent. Changes in health, medications, pregnancy, life circumstances, or recovery can all prompt healthcare providers to reassess treatment.

Factors That Can Affect Buprenorphine/Naloxone Dosage

Healthcare providers consider many factors when deciding whether a person’s treatment plan is working as intended.

Opioid Tolerance

Someone with a long history of opioid use may respond differently than someone with less opioid exposure. Previous opioid use patterns and overall tolerance help providers understand how a person may respond to treatment.

Tolerance is only one piece of the picture. It doesn’t determine treatment by itself.

Withdrawal Symptoms

One of the main goals of buprenorphine/naloxone treatment is controlling opioid withdrawal.

If someone continues to experience withdrawal symptoms despite taking medication as prescribed, their healthcare provider may reassess the treatment plan. If withdrawal symptoms remain well controlled over time, no changes may be necessary.

Withdrawal should always be discussed with the prescribing clinician rather than managed by changing the medication on your own.

Cravings

Ongoing opioid cravings can increase the risk of returning to opioid use.

Healthcare providers may ask about cravings during follow-up visits because they’re an important measure of how well treatment is working. Persistent cravings don’t necessarily mean someone is doing something wrong. Instead, they may signal that the overall treatment plan should be reviewed.

Overall Treatment Response

Healthcare providers look at the complete picture, not just one symptom. Questions they may consider include:

Are withdrawal symptoms controlled?
Have opioid cravings improved?
Is the person able to participate in work, school, family life, or counseling?
Has opioid use decreased or stopped?
Are there concerns about medication adherence or adverse effects?

Together, these factors help providers determine whether treatment remains effective.

Side Effects

Like any medication, buprenorphine/naloxone can cause side effects. Some people experience headache, constipation, nausea, sleep changes, or other effects, particularly when treatment begins. Buprenorphine medicines that dissolve in the mouth can also cause dental problems in some people.

If side effects interfere with daily life, healthcare providers evaluate whether they’ll improve over time or whether the treatment plan should change. If side effects occur, do not abruptly stop treatment on your own. Managing side effects doesn’t always require changing the medication itself, which is one reason open communication with the care team is important.

Coexisting Medical Conditions

Other health conditions and circumstances can also influence treatment decisions. For example, healthcare providers may take additional precautions in people with:

Liver disease
Significant breathing disorders
Certain mental health conditions
Pregnancy
Other chronic medical conditions requiring multiple medications

These conditions don’t necessarily prevent someone from receiving buprenorphine/naloxone, but they may require closer monitoring and individualized treatment planning.

Why Taking More Medication Isn’t Better

It may seem logical to think that taking more medication would produce better results, but that’s not how buprenorphine works.

Buprenorphine has what’s known as a ceiling effect for many of its opioid-related effects. Beyond a certain point, increasing the dose doesn’t necessarily produce greater clinical benefit for withdrawal relief or cravings in every individual. Instead, healthcare providers focus on finding the dose that adequately supports recovery while maintaining safety.

Taking more medication than prescribed can create unnecessary risks and make it harder for providers to evaluate how well treatment is working.

The most effective treatment is the one that’s carefully individualized and monitored over time.

Medications and Substances That Can Affect Treatment

Buprenorphine/naloxone can interact with other medications and substances that affect the central nervous system. Particular caution is needed with:

Alcohol
Benzodiazepines such as alprazolam or diazepam
Prescription sleep medications
Muscle relaxants
Other opioid medications
Certain sedating antihistamines and other drugs that cause drowsiness

Combining these substances can increase the risk of excessive sedation, slowed breathing, overdose, and other serious complications.

The U.S. Food and Drug Administration (FDA) notes that buprenorphine shouldn’t automatically be withheld from people who also take benzodiazepines because untreated OUD also carries significant risks. Instead, careful medical supervision, coordination among prescribers, and close monitoring are recommended.

Always let your healthcare provider know about every prescription medication, over-the-counter medication, vitamin, and supplement you’re taking before starting or continuing treatment.

When You Should Talk With Your Healthcare Provider

Regular communication with your healthcare provider is an important part of successful OUD treatment. Reach out if you notice:

Ongoing withdrawal symptoms
Continued opioid cravings
New or worsening side effects
Difficulty taking medication as prescribed
Changes in your health or newly prescribed medications

Avoid changing your buprenorphine/naloxone dose on your own, even if you feel it’s no longer working or you feel better than before. Your healthcare provider can determine whether your symptoms are related to your medication, recovery, or another medical condition.

Recovery Is a Process, Not a Number

There’s no perfect Suboxone dosage that works for everyone with opioid use disorder. The right treatment plan depends on where you are in recovery, how your body responds, your medical history, and your ongoing symptoms.

Regular follow-up appointments help your healthcare provider monitor withdrawal symptoms, cravings, side effects, and overall progress so treatment remains safe and effective. Recovery isn’t static, and your care plan can change as your needs change.